COMP <GO>
BLLN vs LLY // ALTMAN Z-SCORE & DEBT/EQUITY
BillionToOne Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: BLLN 3
— LLY 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: BLLN
LAST: $113.32 (-1.32%) • MKT CAP: $5.42B
balance-sheet
22.24
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
balance-sheet
9.29
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLLN VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLLN | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 83.64% | -15.34 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 32.36% | -29.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 36.4x | +58.58 | LLY | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 2.30% | -2.01 | LLY | /fcf-yield <GO> |
| Operating Margin | 5.30% | 40.21% | -34.91 | LLY | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 31.90% | -29.50 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 100.00% | 45.51% | +54.49 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 22.24 | 9.29 | +12.95 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.77% | +0.23 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 77.9 | -18.40 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.51 | +0.51 | BLLN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 26.3x | +113.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.42B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLLN REV | LLY REV | BLLN GROSS % | LLY GROSS % | BLLN FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $305.1M | $65.18B | 68.3% | 83.0% | $15.7M | $16.81B |
| FY 2024 | $152.6M | $45.04B | 53.0% | 81.3% | -$46.8M | $8.82B |
| FY 2023 | $71.7M | $34.12B | 44.0% | 79.3% | -$56.9M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLLN // BETA 1.02
LLY // BETA 0.51